The comparative analysis of direct gene therapy, cell therapy, and cell-mediated gene therapy for stroke in rat model revealed the superiority of triple gene (VEGF+GDNF+NCAM) therapy over UCB-MC therapy. This evidence concerns the gene NCAM1 and Stroke.